|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| C12N 5/16 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2471814 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10811290.5 |
| Europos patento paraiškos padavimo data | 2010-08-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2010/076420 |
| Data | 2010-08-27 |
| (87) | Numeris | WO 2011/023130 |
| Data | 2011-03-03 |
| (30) | Numeris | Data | Šalis |
| 200910171550 | 2009-08-28 | CN |
| (72) |
LI, Pierre, US
KE, Yaohuang, US
ZHANG, Yongke, US
ZHU, Weimin, US
YU, Guoliang, US
MA, Fanxin, CN
FAN, Xin, CN
|
| (73) |
Jiangsu Simcere Pharmaceutical Co., Ltd,
No.699-18 Xuanwu Avenue Xuanwu District, Nanjing, Jiangsu 210042,
CN
Apexigen, Inc., 863 Mitten Road, Suite 103, Burlingame, California 94010, US |
| (54) | ANTI-VEGF MONOCLONAL ANTIBODY AND PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTIBODY |
| ANTI-VEGF MONOCLONAL ANTIBODY AND PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTIBODY |